Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Potential Drug Interactions Among Common Medications

Key Interactions

  • The combination of irbesartan, amlodipine, atorvastatin, metformin, magnesium, vitamin D, and tadalafil has several clinically significant interactions that require monitoring, but the current dosages appear safe for most patients with appropriate monitoring 1, 2
  • Amlodipine is a substrate of CYP3A4, and its plasma concentrations may be affected by inhibitors or inducers of this enzyme 2
  • There is no evidence of significant interaction when amlodipine is coadministered with atorvastatin, and this combination therapy may be considered safe 2, 3
  • Tadalafil may enhance the hypotensive effects of irbesartan and amlodipine, potentially causing additive blood pressure reduction 1
  • Monitor for symptoms of hypotension when initiating tadalafil in patients already on antihypertensive therapy 1

Monitoring Recommendations

  • Periodically monitor renal function, particularly with the combination of irbesartan and metformin 5
  • Monitor potassium levels periodically, as irbesartan can cause hyperkalemia in some patients 5
  • Monitor for muscle pain or weakness, which could indicate statin-related myopathy 2, 4

Special Considerations

  • Metformin and irbesartan have complementary effects on insulin sensitivity and may be beneficial in patients with metabolic syndrome 1
  • Vitamin D supplementation has no known significant interactions with any of the medications in this regimen 1
  • Taking metformin with meals can reduce gastrointestinal side effects 1
  • Separating magnesium supplementation from other medications by at least 2 hours may reduce potential for decreased absorption of some drugs 1